Stocks & ETFs

Latest News

Blogs & Articles

Stratagy Backtesting

Portfolio Analyser

Price Analyser

Compare Stocks

Stock & ETF Screener

Pricing

About The Company

CEO

Mr. Edward Manolos

Market Cap

284.11 Thousand USD

Sector

Healthcare

Website

https://www.cannabisglobalinc.com

Description

Cannabis Global, Inc. focuses on the creating and commercialization of engineered technologies to deliver hemp extracts and cannabinoids to the human body.

Read More

Overview

Value

50

Growth

32

Health

42

Management

35

Analyst Opinion

69

Total

46

All Scores Out Of 100

Best Features

  • Earnings growth has improved recently
  • Has a margin-of-safety above fair value
  • Low preportion of income is paid as dividend

Risk Factors

  • Income is not covering expenditure and investment
  • Earnings are negative
  • There is a history of diluting shareholders
  • 0
  • Does not hold enough liquid assets to cover short term liabilities
  • Poor earnings and cashflow growth
  • 0

Market Peers

CBGL

Key Figures

PE Ratio (TTM)

N/A

Margin Of Safety (DCF)

2363.72%

Revenue Growth (5 Year Average)

N/A

Ratings Consensus

Buy

Share Buybacks

-33.95%

Dividend Yeild (TTM)

N/A

Valuation

Value Score

50

  • Margin-of-safety of 2363.72% is better than the market average (17.95%)
  • Estimated intrinsic-value of 12.32 undefined USD is higher than current price ( 500.00 undefined USD)
  • Free-cashflow-yeild of -345.83% is worse than the market average (4.7%)

Desired Margin Of Safety

0%

Tip: Set your desired Margin Of Safety

Free Cash Flow Type

Annual Cashflow Growth

0%

Discount Rate

0%

Buy Target: N/A

Current Price: 0 USD

Negative Cashflows: Cashflow can become negative due to operating losses, investing activities or financing activites. Negative cashflow makes it dificult to use a discounted free cashflow model to assess intrinsic value.

How Does This Work?

Show Advanced Options

This calculator helps investors estimate the Intrinsic Value of a company based on the current value of future cash flows. To use the tool, simply input a desired Margin Of Safety, which is an additional discount applied to the present value of the expected future cash flows. The tool calculates the present value using a discount rate that reflects the risk and time value of money, and provides an estimated target price for the company based on the selected margin of safety. The calculator defaults to using 5 Year Free Cash Flow Growth % and a discount rate based on the US 10-year treasury bond coupon rate. Use our performance analyser to get a feel the impact this has on longterm investment returns and discover a margin of safety you are comfortable with. This can be a useful tool for investors looking to make informed decisions about whether to buy or sell shares of a particular company.

Price/Earnings

N/Ax

Free Cashflow Yeild

-345.83%

PE/Earnings Growth

N/A

Price/Book

0.04x

Growth

Growth Score

32

  • Revenue growth has improved this yeara
  • 5 Year Average Earnings growth of 19.75% is higher than the market average (14.48%)
  • Earnings growth has improved this year
  • Free Cashflow growth has improved this year
  • 5 Year Average Revenue growth of N/A is lower than the market average (10.97%)
  • 5 Year Average Free Cashflow growth of -6.46% is lower than the market average (12.35%)

Revenue Growth

N/A

Earnings Growth

19.75%

Cashflow Growth

-6.46%

Health

Health Score

42

  • Cashflow is negative
  • 0
  • Has a high level of debt
  • Assets do not cover liabilities
  • High financial leverage and base interest rate exposure
  • Requires debt for normal operation to be sustainable
  • Debt repayments significantly impact cashflow

Altman Z Score

N/A

Piostroski Score

4.00

Debt/Equity

1.32x

Current Assets/Liabilities

0.21x

Free Cashflow/Total Debt

N/Ax

Debt/Capital

3.37x

Management

Management Score

35

  • Return-on-capital-employed of 0.30% is lower than the market average (10%)
  • Has issued new shares whilst share price is low
  • Has a history of diluting shareholders to finance activity
  • Return-on-equity of -21.22% is lower than the market average (15%)

Average Buybacks/Dilution

-33.95%

Recent Buybacks/Dilution

9.96%

5 Year Price Volitility

122.98%

Return On Assets

-4.57%

Return On Capital Employed

0.30%

Return On Equity

-21.22%

Return On Free Cashflow

202.04%

Return On Investments

-95.50%

Analysts

Analyst Opinion

69

  • Ratings consensus is Buy

SEC Filings

Find yearly (10-K), quaterly (10-Q) and disclosure (8-K) report here, on the Securities and Exchange Commission's EDGAR database. If reading through reports isn't your cup of tea, don't worry. We've made it easy for you by summarizing all the important bits.

Other Information

Company Name

Cannabis Global, Inc.

Currency

USD

Beta

0.839204

Vol Avg

15617890

Ceo

Mr. Edward Manolos

Cik

0001413488

Cusip

13767G100

Exchange

Other OTC

Full Time Employees

3

Industry

Drug Manufacturers—Specialty & Generic

Sector

Healthcare

Ipo Date

2008-06-19

Address

520 South Grand Avenue

City

Los Angeles

State

CA

Country

US

Zip

90071

Phone

310 986 4929

All financial data provided by FMP

Noticed an error with something on our site?

We Use Cookies